Scancell’s Modi-2 anti-cancer vaccine shows potential in pre-clinical studies Modi-2 is the second vaccine developed from the Moditope platform after Modi-1, and Scancell thinks each one has the potential to treat different types of cancer. [View article] Tuesday 30 October 2018 18:05 Categories: Media Coverage Modi-2 Year - 2018 Previous Post << >> Next Post